eli lilly ceo: competition in pharma | mad money | cnbc
Published 5 years ago • 6.1K plays • Length 9:11Download video MP4
Download video MP3
Similar videos
-
5:33
eli lilly ceo david ricks on 3-year obesity drug study: this is a profound result
-
8:58
insulin pricing: eli lilly ceo | mad money | cnbc
-
6:43
eli lilly ceo on weight loss drugs outlook: our top priority is making more product
-
3:23
market navigator: playing big pharma and eli lilly
-
7:35
eli lilly's zepbound single-dose vials will expand access to more patients: mizuho's jared holz
-
4:22
fda approves a new alzheimer's drug from eli lilly
-
30:33
eli lilly ceo dave ricks on revolutionizing healthcare and medicine
-
6:11
leerink's david risinger talks eli lilly seeing best trading day in a year after earnings
-
4:45
supply chain pressures are rather modest in the pharma sector, says eli lilly ceo
-
8:21
eli lilly ceo talks partnering with abcellera biologics to co-develop a coronavirus cure
-
3:14
eli lilly ceo on raising $1b for antibiotic research: goal is to have two to four new antibiotics
-
6:08
eli lilly ceo on slashing insulin prices, approval timelines for weight-loss and alzheimer's drugs
-
9:43
eli lilly ceo on quarterly earnings beat, pharma policy, and more
-
4:30
eli lilly ceo on fda approval pathway for alzheimer's drugs
-
6:32
eli lilly ceo: drug pricing bill would 'fundamentally restructure' company
-
3:46
eli lilly ceo david ricks on positive alzheimer's drug trial data
-
11:24
eli lilly is ahead of everyone in this business, says jim cramer
-
7:48
eli lilly ceo on drug prices: patients are paying too much out-of-pocket costs
-
2:24
eli lilly may have developed the greatest drug of all time, says jim cramer
-
1:46
eli lilly releases new form of weight loss drug zepbound for half the price to boost access, supply
-
6:49
coronavirus: eli lilly ceo david ricks on development of therapies
-
4:26
eli lilly ceo david ricks breaks down second-quarter earnings and drug pipeline